Mirae Asset Global Investments Co., Ltd. Merus N.V. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Merus N.V. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,281 shares of MRUS stock, worth $94,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,281
Previous 2,467
7.54%
Holding current value
$94,205
Previous $123,000
22.76%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MRUS
# of Institutions
204Shares Held
62MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$172 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$141 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$138 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$119 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$108 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.89B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...